Insights

Growth potential Apollo Endosurgery operates in the medical device space with products used in over 75 countries and has a revenue range of 10-25 million. The company shows room to expand sales through international markets, new clinical applications, and geographic expansion leveraging a scalable device portfolio.

High‑value offerings The portfolio includes minimally invasive solutions like Endoscopic Suturing Systems, HeliX Tacking System, and Intragastric Balloon, which position the company as an alternative to invasive surgery. This supports sales opportunities with hospitals seeking reduced complications and lower total healthcare costs.

Strategic leadership A recent leadership transition involving the CEO role and executive chairmanship at a related company signals potential for new strategic directions, partnerships, or acquisitions. Engage on leadership roadmap, advisory roles, and co‑development opportunities.

Operational footprint With a lean employee base and significant international distribution, there is an opportunity to scale via channel partnerships, regional distributors, and OEM collaborations to accelerate market penetration and service capabilities.

Financial leverage Funding of around 30 million and mid‑range revenue suggest readiness for investment in sales enablement, clinical education, and reimbursements strategy. Target healthcare systems and reimbursement stakeholders to accelerate adoption and patient access.

Similar companies to Apollo Endosurgery

Apollo Endosurgery Tech Stack

Apollo Endosurgery uses 8 technology products and services including HubSpot Analytics, Snowplow, Amazon Web Services, and more. Explore Apollo Endosurgery's tech stack below.

Apollo Endosurgery's Email Address Formats

Apollo Endosurgery uses at least 3 email formats:
Apollo Endosurgery Email FormatsExamplePercentage
First.Last@apolloendo.comJohn.Doe@apolloendo.com
96%
First.Middle@apolloendo.comJohn.Michael@apolloendo.com
3%
Last@apolloendo.comDoe@apolloendo.com
1%

Frequently Asked Questions

What is Apollo Endosurgery's phone number?

Minus sign iconPlus sign icon
You can contact Apollo Endosurgery's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Apollo Endosurgery's stock symbol?

Minus sign iconPlus sign icon
Apollo Endosurgery is a publicly traded company; the company's stock symbol is APEN.

What is Apollo Endosurgery's official website and social media links?

Minus sign iconPlus sign icon
Apollo Endosurgery's official website is apolloendo.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Apollo Endosurgery generate?

Minus sign iconPlus sign icon
As of October 2026, Apollo Endosurgery's annual revenue is estimated to be $10M - $25M.

What is Apollo Endosurgery's SIC code and NAICS code?

Minus sign iconPlus sign icon
Apollo Endosurgery's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Apollo Endosurgery have currently?

Minus sign iconPlus sign icon
As of October 2026, Apollo Endosurgery has approximately 144 employees across 6 continents, including North America, Asia and Europe. Key team members include Chief Financial Officer: J. B., Vice President Manufacturing Operations: F. L. N. and Vice President, Us Sales: B. S. Explore Apollo Endosurgery's employee directory with LeadIQ.

What industry does Apollo Endosurgery belong to?

Minus sign iconPlus sign icon
Apollo Endosurgery operates in the Medical Equipment Manufacturing industry.

What technology does Apollo Endosurgery use?

Minus sign iconPlus sign icon
Apollo Endosurgery's tech stack includes HubSpot Analytics, Snowplow, Amazon Web Services, Drupal, WordPress, OneTrust, Google Cloud and New Relic.

What is Apollo Endosurgery's email format?

Minus sign iconPlus sign icon
Apollo Endosurgery's email format typically follows the pattern of First.Last@apolloendo.com. Find more Apollo Endosurgery email formats with LeadIQ.

How much funding has Apollo Endosurgery raised to date?

Minus sign iconPlus sign icon
As of October 2026, Apollo Endosurgery has raised $30M in funding. The last funding round occurred on Jan 21, 2022 for $35M.

When was Apollo Endosurgery founded?

Minus sign iconPlus sign icon
Apollo Endosurgery was founded in 2006.
Apollo Endosurgery logo

Apollo Endosurgery

Medical Equipment ManufacturingTexas, United States51-200 Employees

Apollo Endosurgery is a medical technology company focused on developing less invasive devices for therapeutic endoscopy to treat a range of gastrointestinal conditions, including closure of GI defects, management of GI complications, and obesity treatment. Its device-based therapies are intended as alternatives to invasive surgical procedures, aiming to reduce complication rates and total healthcare costs. The company is based in Austin, Texas, and operates as a mid-sized organization with products deployed in more than 75 countries. Its customer base comprises healthcare providers, including hospitals and clinics that perform endoscopic therapies, seeking non-surgical options for GI care. In late 2022, Boston Scientific announced the acquisition of Apollo Endosurgery.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
APEN
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $30M

    Apollo Endosurgery has raised a total of $30M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2022 in the amount of $35M as a Post IPO Debt.

  • $10M - $25M

    Apollo Endosurgery's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.